Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWindar Photo Regulatory News (WPHO)

Share Price Information for Windar Photo (WPHO)

Share Price is delayed by 15 minutes
Get Live Data
26.75    -0.50 (-1.83%)
Bid:
26.50
Ask:
27.00
Spread: 0.50 (1.887%)
Market Cap: £26.28m
WPHO Live PriceLast checked at - London Stock Exchange

Intraday Windar Photo Share Chart

Correction: Director/PDMR Shareholding

28 May 2026 10:45

RNS Number : 0695G
Windar Photonics PLC
28 May 2026
 

 

 

28 May 2026

("Windar" or the "Company")

Correction: Director/PDMR Shareholding

Windar Photonics plc (AIM: WPHO), the technology group that has developed a LiDAR wind sensor and software suite designed to monitor and optimise wind turbine performance across multiple turbine platforms, announces corrections to previously published director and PDMR shareholding announcements in respect of David Lis, Interim Executive Chairman.

Background

The directorate changes announcement published on 6 October 2023 disclosed Mr Lis' personal holding of 337,500 ordinary shares at the date of his appointment as Non-Executive Chairman. It did not disclose the holding of 50,000 ordinary shares held at that date by Patricia Lis, wife of Mr Lis and a person closely associated with him for the purposes of the UK Market Abuse Regulation. The total beneficial interest of Mr Lis and his connected persons at the date of appointment should therefore have been stated as 387,500 ordinary shares.

As a result of this omission, the combined beneficial interest of Mr Lis and his connected persons was understated in subsequent director and PDMR shareholding announcements.

In addition, the director/PDMR shareholding announcements published on 26 March 2025 and 14 April 2025 reported the combined beneficial interest of Mr Lis and his connected persons following bed-and-ISA transactions. The net cost of those transactions resulted in a reduction of 420 ordinary shares across those announcements that was not correctly reflected in the combined holding in the RNS dated 26 March 2026. The correct combined holding in the RNS dated 26 March 2026 should have been 2,258,181.

Current Holding

Taking into account both corrections above, the correct current total beneficial interest of David Lis and his connected persons is 2,258,181 ordinary shares, representing 2.33% of the Company's issued share capital.

For further information, please contact:

Windar Photonics plc

 

David Lis, Interim Executive Chairman

Søren Belmar, CFO / COO

Via Novella

Tel: +45 53527276

Zeus (Nominated Adviser and Broker)

 

David Foreman / James Bavister

Tel: +44 (0) 20 3829 5000

Novella Communications

 

Tim Robertson / Aeliya Bilgrami

Tel: +44 (0) 20 3151 7008

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEANSPALFKEEA
Date   Source Headline
3rd Jun 202611:54 amRNSCEO Appointment, Grant of Options and RPT
28th May 202610:45 amRNSCorrection: Director/PDMR Shareholding
21st Apr 20267:00 amRNSCEO Appointment
20th Apr 202612:15 pmRNSHolding(s) in Company
20th Apr 202611:45 amRNSHolding(s) in Company
15th Apr 20267:00 amRNSTrading Update & £20m Share Subscription Facility
26th Mar 20261:30 pmRNSIssue of Equity in Lieu of Non-Executive Fees
16th Jan 20266:22 pmRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSDirectorate change
23rd Dec 20257:00 amRNSTrading Statement
23rd Dec 20257:00 amRNSTrading Statement
15th Dec 20257:00 amRNSChange of Adviser
13th Nov 20259:41 amRNSHolding(s) in Company
20th Oct 20257:00 amRNSDirectorate Change
15th Sep 20257:00 amRNSHalf-year Report
8th Sep 20257:00 amRNS-RSenior Management Appointment
13th Aug 20257:00 amRNS-RSenior Management Appointment
11th Aug 20257:00 amRNSNew $2.6m Order For The US Market
1st Aug 202512:27 pmRNSResult of AGM
1st Aug 20257:00 amRNSAGM Statement
1st Jul 20257:00 amRNSFinal Results
11th Jun 20257:00 amRNSUpdate on Expectations
9th Jun 20257:00 amRNSDirectorate Change
19th May 20257:00 amRNS-RWindar Photonics to Exhibit at CLEANPOWER 2025
30th Apr 20257:00 amRNSWind Sector Leaders Join New Advisory Board
14th Apr 20257:00 amRNSDirector/PDMR Shareholding
26th Mar 20255:19 pmRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSTrading Update and First Discreet Software Order
26th Feb 202512:41 pmRNSIssue of Equity in Lieu of Directors' Fees
31st Dec 20247:00 amRNSTotal Voting Rights
18th Dec 20247:00 amRNSMaterial New US Order
10th Dec 20242:30 pmRNSTR-1: Notification of Major Holdings
6th Dec 20244:41 pmRNSTR-1: Notification of Major Holdings
6th Dec 20244:31 pmRNSTR-1: Notification of Major Holdings
3rd Dec 20248:00 amRNSResult of oversubscribed placing
2nd Dec 20244:35 pmRNSProposed placing to raise £5.5 million
12th Nov 20247:00 amRNSTrading Update
19th Sep 20245:34 pmRNSAIM Rule 17 Schedule 2 (G) Update
12th Sep 20247:00 amRNSUn-audited Results for the 6 months ended 30 June
5th Aug 20244:52 pmRNSResults of AGM
5th Aug 20247:00 amRNSAGM Trading Update
1st Aug 202410:44 amRNSAppointment of Broker
19th Jul 202410:36 amRNSDirectorate Change and Director Disclosures
15th Jul 20247:00 amRNSChange of Nominated Adviser
11th Jul 20249:13 amRNSPosting of Annual Report and Notice of AGM
4th Jul 20245:33 pmRNSAIM Rule 17 Schedule 2 (G) Update
1st Jul 20247:00 amRNSAudited Results, Trading Update and Notice of AGM
3rd May 202410:37 amRNSDirectors Dealing / PDMR Shareholding
22nd Apr 20249:38 amRNSDirector Dealing
18th Apr 20245:30 pmRNSDirector dealing / PDMR shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.